Insider holders · CIK 0001473579
Boston Therapeutics, Inc. · BTHE
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| David PlattCEO and Chairman | 7,561,985 | — | 7,561,985 | May 18, 2015 · 1:35 pm EDT | Form 4 |
| Loraine UphamChief Operating Officer | 777,429 | — | 777,429 | Mar 7, 2018 · 6:31 pm EST | Form 3 |
| Anthony Don SquegliaChief Financial Officer | 128,350 | — | 128,350 | Mar 11, 2015 · 2:41 pm EDT | Form 4 |
| Henry Jemil EsberDirector | 13,000 | — | 13,000 | Mar 20, 2015 · 4:26 pm EDT | Form 4 |
| Dale H ConawayDirector | 7,100 | — | 7,100 | Jun 8, 2015 · 1:12 pm EDT | Form 4 |
| Alan M HobermanDirector | 5,000 | — | 5,000 | Mar 16, 2015 · 2:52 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.